| Secondary |
| Hypertension |
27.9% |
| Myocardial Infarction |
8.8% |
| Cardiac Failure |
7.7% |
| Drug Use For Unknown Indication |
7.3% |
| Maternal Exposure Timing Unspecified |
7.1% |
| Percutaneous Coronary Intervention |
6.5% |
| Product Used For Unknown Indication |
6.5% |
| Suicide Attempt |
4.2% |
| Prophylaxis |
4.0% |
| Polyuria |
3.5% |
| Hyperlipidaemia |
2.3% |
| Fluid Retention |
2.1% |
| Nephrotic Syndrome |
1.9% |
| Insomnia |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Angina Pectoris |
1.5% |
| Constipation |
1.5% |
| Gastritis Prophylaxis |
1.5% |
| Thrombosis Prophylaxis |
1.5% |
| Arrhythmia |
1.3% |
|
| Interstitial Lung Disease |
14.3% |
| Cardiac Arrest |
7.1% |
| Hyponatraemia |
7.1% |
| Renal Failure Acute |
7.1% |
| Renal Impairment |
7.1% |
| Agranulocytosis |
5.7% |
| Completed Suicide |
5.7% |
| Renal Aplasia |
5.7% |
| Cerebral Infarction |
4.3% |
| Cholecystitis Chronic |
4.3% |
| Decreased Appetite |
4.3% |
| Foetal Exposure During Pregnancy |
4.3% |
| Rash |
4.3% |
| Blood Creatinine Increased |
2.9% |
| Cardio-respiratory Arrest |
2.9% |
| Dehydration |
2.9% |
| Fatigue |
2.9% |
| Pyrexia |
2.9% |
| Thrombocytopenia |
2.9% |
| Alanine Aminotransferase Increased |
1.4% |
|
| Concomitant |
| Hypertension |
31.8% |
| Product Used For Unknown Indication |
12.9% |
| Diabetes Mellitus |
5.0% |
| Drug Use For Unknown Indication |
5.0% |
| Prophylaxis |
4.3% |
| Cardiac Failure |
4.0% |
| Constipation |
3.8% |
| Hepatitis C |
3.8% |
| Insomnia |
3.5% |
| Cardiac Failure Chronic |
3.4% |
| Rheumatoid Arthritis |
3.3% |
| Gastritis |
3.0% |
| Breast Cancer |
2.7% |
| Atrial Fibrillation |
2.4% |
| Hyperuricaemia |
2.1% |
| Pulmonary Hypertension |
2.0% |
| Multiple Myeloma |
2.0% |
| Hiv Infection |
1.7% |
| Hyperlipidaemia |
1.7% |
| Gastric Ulcer |
1.6% |
|
| Cardiac Failure |
9.5% |
| Pneumonia |
8.5% |
| Vomiting |
7.5% |
| Thrombocytopenia |
7.0% |
| Weight Increased |
6.5% |
| Renal Impairment |
6.0% |
| Interstitial Lung Disease |
5.5% |
| Rhabdomyolysis |
5.0% |
| Pyrexia |
4.5% |
| Cerebral Infarction |
4.0% |
| Hyponatraemia |
4.0% |
| Malaise |
4.0% |
| Renal Failure |
4.0% |
| Sepsis |
4.0% |
| White Blood Cell Count Decreased |
4.0% |
| Dizziness |
3.5% |
| Rash |
3.5% |
| White Blood Cell Count Increased |
3.5% |
| Agranulocytosis |
3.0% |
| Anaemia |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
46.2% |
| Drug Use For Unknown Indication |
30.8% |
| Nasopharyngitis |
15.4% |
| Gonalgia |
7.7% |
|
| Cardiac Arrest |
50.0% |
| Toxicity To Various Agents |
50.0% |
|
